Intrauterine insemination is a relatively simple and safe procedure, and the risk of serious complications is low. Risks associated with use of ovulation induction drugs include:
- OHSS (Ovarian Hyperstimulation Syndrome): If your treatment plan also involves ovulation induction, there is a small risk of Ovarian Hyperstimulation Syndrome (OHSS), where a woman over-responds to the ovulation hormones and can become either moderately or severely unwell. IUI cycles are monitored by ultrasound scans and sometimesblood tests and medication doses are adjusted to avoid OHSS or the treatment cycle is cancelled if there is a risk of OHSS.
- Multiple pregnancy: If a woman is taking fertility medications when she has IUI, her chance of getting pregnant with twins or triplets is greater than if she were not taking fertility medications as more than one follicle might develop.